pan-KRAS inhib 
Welcome,         Profile    Billing    Logout  
  Companies    Products    Products    Diseases    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
            
             
BI 1701963 / Boehringer Ingelheim           
          
            
             
ADXS-503 / Ayala Pharma